(Q45145307)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Characterising aggressive multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Helen Tremlett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Suresh Menon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Afsaneh Shirani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yinshan Zhao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Joel Oger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Mark S Freedman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

6 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurology, Neurosurgery and Psychiatry

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1192-1198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744892%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Aggressive multiple sclerosis-is there a role for stem cell transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Demographic and clinical characteristics of malignant multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Marburg type and Bal�?s concentric sclerosis: rare and acute variants of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

High dose cyclophosphamide treatment in Marburg variant multiple sclerosis A case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Fulminant multiple sclerosis (MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

The natural history of primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

New perspectives in the natural history of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Clinical prognostic factors in multiple sclerosis: a natural history review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Benign multiple sclerosis: a new definition of this entity is needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Disability progression in multiple sclerosis is slower than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Age and disability accumulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Long-term results of stem cell transplantation for MS: A single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Natural history of secondary-progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951

Longitudinal follow-up of "benign" multiple sclerosis at 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-304951